The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology - PubMed (original) (raw)
. 1996 Oct;2(10):1146-50.
doi: 10.1038/nm1096-1146.
F Lopera, K S Kosik, C L Lendon, J Ossa, T C Saido, H Yamaguchi, A Ruiz, A Martinez, L Madrigal, L Hincapie, J C Arango, D C Anthony, E H Koo, A M Goate, D J Selkoe, J C Arango
Affiliations
- PMID: 8837617
- DOI: 10.1038/nm1096-1146
The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology
C A Lemere et al. Nat Med. 1996 Oct.
Abstract
Missense mutations in the presenilin 1 (PS1) gene cause the most common form of dominant early-onset familial Alzheimer's disease (FAD) and are associated with increased levels of amyloid beta-peptides (A beta) ending at residue 42 (A beta 42) in plasma and skin fibroblast media of gene carriers. A beta 42 aggregates readily and appears to provide a nidus for the subsequent aggregation of A beta 40 (ref. 4), resulting in the formation of innumerable neuritic plaques. To obtain in vivo information about how PS1 mutations cause AD pathology at such early ages, we characterized the neuropathological phenotype of four PS1-FAD patients from a large Colombian kindred bearing the codon 280 Glu to Ala substitution (Glu280Ala) PS1 mutation. Using antibodies specific to the alternative carboxy-termini of A beta, we detected massive deposition of A beta 42, the earliest and predominant form of plaque A beta to occur in AD (ref. 6-8), in many brain regions. Computer-assisted quantification revealed a significant increase in A beta 42, but not A beta 40, burden in the brains from 4 PS1-FAD patients compared with those from 12 sporadic AD patients. Severe cerebellar pathology included numerous A beta 42-reactive plaques, many bearing dystrophic neurites and reactive glia. Our results in brain tissue are consistent with recent biochemical evidence of increased A beta 42 levels in PS1-FAD patients and strongly suggest that mutant PS1 proteins alter the proteolytic processing of the beta-amyloid precursor protein at the C-terminus of A beta to favor deposition of A beta 42.
Similar articles
- Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease.
Sepulveda-Falla D, Matschke J, Bernreuther C, Hagel C, Puig B, Villegas A, Garcia G, Zea J, Gomez-Mancilla B, Ferrer I, Lopera F, Glatzel M. Sepulveda-Falla D, et al. Brain Pathol. 2011 Jul;21(4):452-63. doi: 10.1111/j.1750-3639.2010.00469.x. Epub 2011 Jan 27. Brain Pathol. 2011. PMID: 21159009 Free PMC article. - The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
Gómez-Isla T, Growdon WB, McNamara MJ, Nochlin D, Bird TD, Arango JC, Lopera F, Kosik KS, Lantos PL, Cairns NJ, Hyman BT. Gómez-Isla T, et al. Brain. 1999 Sep;122 ( Pt 9):1709-19. doi: 10.1093/brain/122.9.1709. Brain. 1999. PMID: 10468510 - Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.
Sepulveda-Falla D, Barrera-Ocampo A, Hagel C, Korwitz A, Vinueza-Veloz MF, Zhou K, Schonewille M, Zhou H, Velazquez-Perez L, Rodriguez-Labrada R, Villegas A, Ferrer I, Lopera F, Langer T, De Zeeuw CI, Glatzel M. Sepulveda-Falla D, et al. J Clin Invest. 2014 Apr;124(4):1552-67. doi: 10.1172/JCI66407. Epub 2014 Feb 24. J Clin Invest. 2014. PMID: 24569455 Free PMC article. - The gene defects responsible for familial Alzheimer's disease.
Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W. Tanzi RE, et al. Neurobiol Dis. 1996;3(3):159-68. doi: 10.1006/nbdi.1996.0016. Neurobiol Dis. 1996. PMID: 8980016 Review. - Genes implicated in the pathogenesis of Alzheimer's disease.
Das HK, Lal H. Das HK, et al. Front Biosci. 1997 Jun 1;2:d253-9. doi: 10.2741/a188. Front Biosci. 1997. PMID: 9206974 Review.
Cited by
- Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics study.
Fiorini A, Sultana R, Förster S, Perluigi M, Cenini G, Cini C, Cai J, Klein JB, Farr SA, Niehoff ML, Morley JE, Kumar VB, Butterfield DA. Fiorini A, et al. Free Radic Biol Med. 2013 Dec;65:1-14. doi: 10.1016/j.freeradbiomed.2013.06.017. Epub 2013 Jun 15. Free Radic Biol Med. 2013. PMID: 23777706 Free PMC article. - Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.
Larner AJ, Doran M. Larner AJ, et al. J Neurol. 2006 Feb;253(2):139-58. doi: 10.1007/s00415-005-0019-5. Epub 2005 Nov 4. J Neurol. 2006. PMID: 16267640 Review. - Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization.
Schenk D, Games D, Seubert P. Schenk D, et al. J Mol Neurosci. 2001 Oct;17(2):259-67. doi: 10.1385/JMN:17:2:259. J Mol Neurosci. 2001. PMID: 11816797 Review. - Toward the structure of presenilin/γ-secretase and presenilin homologs.
Wolfe MS. Wolfe MS. Biochim Biophys Acta. 2013 Dec;1828(12):2886-97. doi: 10.1016/j.bbamem.2013.04.015. Biochim Biophys Acta. 2013. PMID: 24099007 Free PMC article. Review. - Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease.
Sepulveda-Falla D, Matschke J, Bernreuther C, Hagel C, Puig B, Villegas A, Garcia G, Zea J, Gomez-Mancilla B, Ferrer I, Lopera F, Glatzel M. Sepulveda-Falla D, et al. Brain Pathol. 2011 Jul;21(4):452-63. doi: 10.1111/j.1750-3639.2010.00469.x. Epub 2011 Jan 27. Brain Pathol. 2011. PMID: 21159009 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases